Read More Pharma Industry News Breakthrough in oral lichen planus? Lipella Pharmaceuticals’ LP-310 delivers promising results Lipella Pharmaceuticals has announced encouraging topline results from its Phase 2a dose-ranging trial for LP-310, a liposomal-tacrolimus oral… byPallavi MadhirajuFebruary 11, 2025